XML 61 R50.htm IDEA: XBRL DOCUMENT v3.25.3
COMMITMENTS AND CONTINGENCIES (Details)
3 Months Ended 9 Months Ended
Dec. 20, 2024
Jul. 15, 2015
USD ($)
Sep. 30, 2025
USD ($)
Director
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
Director
Sep. 30, 2024
USD ($)
Commitments and Contingencies [Line Items]            
Number of pending or threatened lawsuits     0   0  
Office space lease renewed term     1 year   1 year  
Operating lease costs     $ 5,573 $ 4,938 $ 15,340 $ 24,067
Number of non audit committee chairs     2   2  
Licensed technology term.   20 years        
Annual royalty payment   5.00%        
Percentage of royalty payments of net sales 4.00%          
Percentage of revenue 20.00%          
Charles Allen [Member]            
Commitments and Contingencies [Line Items]            
Cash compensation     $ 2,000   $ 2,000  
Paul Field [Member]            
Commitments and Contingencies [Line Items]            
Cash compensation     1,250   1,250  
US Government Sales [Member]            
Commitments and Contingencies [Line Items]            
Royalty expense   $ 35,000,000        
U.S. Army Agreement [Member]            
Commitments and Contingencies [Line Items]            
Royalty expense   $ 35,000,000        
Tufts MC Agreement [Member]            
Commitments and Contingencies [Line Items]            
Royalty expense         0  
Board of Directors Chairman [Member]            
Commitments and Contingencies [Line Items]            
Annual royalty payment   3.00%        
Board of Directors Chairman [Member] | Stephen Toovey [Member]            
Commitments and Contingencies [Line Items]            
Cash compensation     $ 11,250   $ 11,250  
Director [Member]            
Commitments and Contingencies [Line Items]            
Number of director nominees | Director     4   4  
Equity-based compensation awards term         annual  
Minimum [Member]            
Commitments and Contingencies [Line Items]            
Percentage of treatment of babesiosis 2.00%          
Maximum [Member]            
Commitments and Contingencies [Line Items]            
Percentage of treatment of babesiosis 10.00%          
IPO [Member]            
Commitments and Contingencies [Line Items]            
Payment     $ 10,000,000   $ 10,000,000